StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Compass Pathways (CMPS) PT Raised to $17 at Morgan Stanley
May 14, 2026 8:52 AM
Morgan Stanley analyst Judah C. Frommer raised the price target on Compass Pathways (NASDAQ:
CMPS
) to $17.00 (from $16.00) while maintaining a Overweight rating.
Categories
Analyst PT Change